The scientific advisory board consists of individuals who have expertise in microbiology and immunology, and a strong commitment to research in biodefense and emerging infectious diseases:

• Fred Sparling, University of North Carolina, Chapel Hill
• Richard Whitley, University of Alabama at Birmingham
• Gail Cassell, Vice President of Infectious Diseases, Eli Lilly and Company
• Mary Estes, Baylor University
• Bernard Roizmann, University of Chicago